Company Filing History:
Years Active: 2000
Title: Luis Carvalho: Innovator in Tetracycline Preparation
Introduction
Luis Carvalho is a notable inventor based in Seixal, Portugal. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of tetracyclines, which are essential in therapeutic applications. His innovative approach has led to the development of a unique process that enhances the efficacy of these compounds.
Latest Patents
Carvalho holds a patent for a process titled "Process for the preparation of 4-(des-dimethylamino)-tetracyclines." This invention involves treating starting tetracyclines with a methylating agent, followed by the reduction of the resulting trimethylammonium salts through electrolysis in an aqueous solution at acidic pH. The process utilizes a direct electrical current with a potential of 0.5-1.5 volts applied between two electrodes until the reaction is complete. The final product, 4-(des-dimethylamino)-tetracyclines, is isolated through extraction with an organic solvent. This patent highlights Carvalho's innovative approach to enhancing the therapeutic applications of tetracyclines.
Career Highlights
Luis Carvalho is currently associated with Hovione Inter Limited, a company known for its expertise in pharmaceutical manufacturing. His work at Hovione has allowed him to focus on developing processes that improve drug formulations and delivery systems. Carvalho's dedication to innovation in the pharmaceutical industry has positioned him as a key player in his field.
Collaborations
Throughout his career, Carvalho has collaborated with esteemed colleagues such as William Heggie and Jose Manuel Galindro. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Luis Carvalho's contributions to the preparation of tetracyclines demonstrate his commitment to innovation in the pharmaceutical industry. His patented process not only enhances the therapeutic potential of these compounds but also reflects his dedication to improving healthcare solutions.